Solas Health & Wellness in El Paso offers non-surgical, medically supervised weight loss: GLP-1 injections including semaglutide (the medication in Ozempic and Wegovy) and tirzepatide (the medication in Mounjaro and Zepbound), plus AOD peptide therapy, lipotropic (MIC) and B12 fat-burner injections, and oral appetite-management options where appropriate
Ongoing research focuses on developing functionalized nanoparticles and advanced imaging technologies to enhance targeting accuracy and minimize off-target effects
Treatment timelines vary based on individual goals, progress, and provider recommendations
Inibizione In caso di iperglicemia e scorte di glicogeno sature, il fegato inizia la liposintesi producendo acidi grassi e trigliceridi a partire dal glucosio in eccesso
Theyre regulated by the Drug Quality and Security Act (DQSA), which requires compounders to meet certain conditions
10.1111/j.1463-1326.2009.01158.x 63